Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) [U01]

The summary for the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) [U01] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) [U01]: -The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support of the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium by the National Cancer Institute (NCI). The original CanCORS program was established to collect information on approximately 10,000 newly diagnosed lung and colorectal cancer patients. The current reissuance of the program will continue to support follow up studies on the CanCORS-associated lung and colorectal cancer patient cohorts. The currently funded CanCORS Consortium has collected extensive information about medical care received by these cancer patients over the initial acute treatment phase along with information on the clinical and patient-reported outcomes experienced by the patients during this phase. This FOA provides the next phase of funding for a detailed assessment of the quality of follow-up care and the health outcomes among longer-term survivors of lung and colorectal cancer. Dissemination of CanCORS data is also a distinct objective. The currently funded CanCORS Consortium consists of separate awards for a Statistical Coordinating Center (SCC) and seven Primary Data Collection and Research Sites (PDCRs). To allow for a tighter integration in the continuation of the program, all individual components will be supported by one award. Therefore, this FOA solicits a single, joint application from the current SCC and the PDCR awardee institutions that will consolidate these components under a single organizational entity for the next round of follow-up studies on the two CanCORS patient cohorts.-Mechanism of Support. This FOA will utilize the NIH cooperative agreement (U01) funding mechanism.